Effectiveness of quadruple therapy using lansoprazole, instead of omeprazole, in curing Helicobacter pylori infection

Helicobacter

Volumn 1, Issue 3, 1996, Pages 145-150

  De Boer, Wink A ^a   Van Etten, Ruud J X M ^a   Lai, J Y L ^a   Schneeberger, Peter M ^a   Van De Wouw, Branka A M ^a   Driessen, Willem M M ^b  

^a ST ANNA HOSPITAL   (Netherlands)

^b ST JOSEPH HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ANTACID AGENT; ANTIULCER AGENT; BACTERIAL PROTEIN; BISMUTH CITRATE; CARBON; DIAGNOSTIC AGENT; DRUG DERIVATIVE; ENZYME INHIBITOR; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; ORGANOMETALLIC COMPOUND; PROTON PUMP; TETRACYCLINE; UREA; UREASE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BREATH ANALYSIS; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; DYSPEPSIA; ENZYMOLOGY; FEMALE; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; MULTICENTER STUDY; PEPTIC ULCER; PROSPECTIVE STUDY; TREATMENT OUTCOME;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; ANTACIDS; ANTI-ULCER AGENTS; BACTERIAL PROTEINS; BREATH TESTS; CARBON ISOTOPES; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; DYSPEPSIA; ENZYME INHIBITORS; FEMALE; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; ORGANOMETALLIC COMPOUNDS; PEPTIC ULCER; PROSPECTIVE STUDIES; PROTON PUMPS; TETRACYCLINE; TREATMENT OUTCOME; UREA; UREASE;

EID: 0030223413     PISSN: 10834389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-5378.1996.tb00028.x     Document Type: Article

References (14)

1. National Institute of Health. Consensus conference. Helicobacter pylori in peptic ulcer disease. JAMA 1994;272:65-9.
2. Tytgat GNJ. Review article: H. pylori infection and duodenal ulcer disease. J Intern Med 1992; 231: 199-203.
3. de Boer WA, Tytgat GNJ. The best therapy for Helicobacter pylori infection: Should efficacy or side effect profile determine our choice? Scand J Gastroenterol 1995;30:401-7.
4. Forbes GM, Glaser ME, Cullen DJE, et al. Duodenal ulcer treated with Helicobacter pylori eradication: Seven year follow-up. Lancet 1994;343:258-60.
5. Thys JC, Kuipers EJ, van Zwet AA, Pena AS, de Graaf J. Treatment of Helicobacter pylori infections. Q J Med 1995;88:369-89.
6. de Boer WA, Tytgat GNJ. Ninety percent cure: Which anti-Helicobacter therapy can achieve this treatment goal [editorial]? Am J Gastroenterol 1995;90:1381-2.
7. Hosking SW, Ling TKW, Yung MY, Cheng A, Chung SCS, Leung JWC, Li AKC. Randomised controlled trial of short term treatment to eradicate H. pylori in patients with duodenal ulcer. Br Med J 1992;305:502-4.
8. de Boer WA, Driessen WMM, Jansz AR, Tytgat GNJ. Quadruple therapy compared with dual therapy for eradication of H. pylori in ulcer patients: Results of a randomized prospective single-centre study. Eur J Gastroenterol Hepatol 1995;7:1189-94.
9. de Boer WA, Driessen WMM, Jansz AR, Tytgat GNJ. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995;345:817-20.
10. Hosking SW, Ling TKW, Chung SCS, Yung MY, Cheng AFB, Sung JJY, Li AKC. Duodenal ulcer healing by eradication of H. pylori without anti-acid treatment: randomised controlled trial. Lancet 1994;343:508-10.
11. Deskalopoulos G, Carrick J, Lian R, Lee A. Optimising therapy for H. pylori gastritis (abstract) Ir J Med Sci 1992; 161 (Suppl 10):16.
12. Borody TJ, Andrews P, Fracchia G, Brandl S, Shortis NP, Bae H. Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut 1995;37:477-81.
13. Spencer CM, Faulds D. Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders. Drugs 1994;48:404-30.
14. Nagata K, Takagi E, Tsuda M, Nakazawa T, Satoh H, Nakao M et al. Inhibitory action of lansoprazole and its analogs against H. pylori: Inhibition of growth is not related to inhibition of urease. Antimicrob Agents Chemother 1995;39:567-70.